Name | Title | Contact Details |
---|
DNA2.0 is a privately-held, leading synthetic genomics company, headquartered in Menlo Park, CA.
The New York Genome Center (NYGC) is at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. Our member organizations are united in this unprecedented collaboration of technology, science, and medicine. We implement advanced genomic research, and integrate our findings with world-class technologies and physician-scientists in order to help solve diseases. We harness the diversity of New York`s institutions and people to drive scientific discoveries that will vastly improve clinical care — ethically, equitably and urgently. We advocate and educate, sharing our findings with the global scientific, medical and thought leadership communities to broaden the reach of the New York Genome Center to help patients in every corner of the world. We create synergies through collaboration to continually innovate and advance our vision.
EXIM-INDIS is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Zotos International, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Darien, CT. To find more information about Zotos International, Inc., please visit www.zotos.com
UC San Diego Health Sciences has long been known as a place where discoveries are made. Today, we are known as a place where discoveries are delivered. UC San Diego Health Sciences encompasses the School of Medicine, the Skaggs School of Pharmacy and Pharmaceutical Sciences, and UC San Diego Health System, including UC San Diego Medical Center, in Hillcrest; and in La Jolla, Thornton Hospital, Moores Cancer Center, Sulpizio Cardiovascular Center; and other centers, primary and specialty practices of the UC San Diego Medical Group faculty physicians. As a top-tier academic medical center, its role is to provide leadership in improving health through research, education and patient care. UC San Diego Health Sciences has long been at the forefront of “bench-to-bedside” research, transforming patient care through discovery and innovation leading to new drugs and technologies. It is carried out every day in the hundreds of clinical trials of promising new therapies offered through UC San Diego Health System, and in the drive of our researchers and clinician-scientists who are committed to having a significant impact on patient care. At UC San Diego Health Sciences, there are many discoveries on our horizon. Our commitment is to continue our quest to cure disease, seek better treatments and train the next generation of physicians and scientists.